Lyka Labs share news, announcements and annual reports
NSE: LYKALABSBSE: 500259Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹76.60.
2 Nov: open ₹76.00, high ₹76.00, low ₹75.07
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹271 Cr2,310th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.83
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −4.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −3.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.47
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 15,895
Lyka Labs share news and announcements
1,493 announcements, routine notices left out, newest first. Page 28 of 30.
May 2011
14 May · Results
12 May · Board meeting
Company had informed the Exchange regarding a Board meeting to be held on May 13, 2011 to consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended March 31, 2011. The Company has now informed the Exchange that since the majority of the Directors are not available on May 13, 2011 the Company has therefore adjourned the Board Meeting on May 14, 2011 to consider and take on record Un-audited Standalone and Consolidated Financial Results for the Quarter ended March 31, 2011.5 May · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended March 31, 2011.
Mar 2011
29 Mar · Lyka Labs Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 25, 2011 to April 29, 2011 (both days inclusive) for the ....
Fixes Book Closure for AGM28 Mar · Meeting
Board has fixed the date of Annual General Meeting as on April 29, 2011 and the Share Transfers Books and Registrar of Members will remain closed for a period of 5 days from April 25, 2011 to April 29, 2011 (both days inclusive) for the purpose of Annual General Meeting.25 Mar · Results
21 Mar · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on March 23, 2011 to consider and take on record the Audited Annual Accounts for the year ended September 30, 2010 and to consider the Consolidated Audited Annual Accounts of the Company for the year ended September 30, 2010. The Company has now informed the Exchange that due to unavoidable circumstances the meeting of the Board of Directors of the Company which was scheduled to be held on March 23, 2011 has been postponed to March 25, 2011.16 Mar · Board meeting
To consider and take on record the Audited Annual Accounts for the year ended September 30, 2010 and to consider the Consolidated Audited Annual Accounts of the Company for the year ended September 30, 2010.10 Mar · Meeting
For financial year ended September 30, 2010, the Company have sought an extension of one month from the Registrar of Companies, Gujarat vide their letter dtd March 01, 2011 for holding Annual General Meeting upto April 30, 2011.7 Mar · Lyka Labs Ltd has informed BSE that for financial year ended September 30, 2010, the Company have sought an extension of one month from the Registrar of Companies, Gujarat vide their letter ....
Extension of AGM
Feb 2011
24 Feb · Limited Review for the quarter ended Dec 31, 2010
15 Feb · Results
15 Feb · Board meeting
To consider and take on record the Un-audited Financial Results and also Consolidated Financial Results of the Company for the quarter ended December 31, 2010.
Jan 2011
Dec 2010
Nov 2010
22 Nov · Lyka Labs Ltd has informed BSE that Mr. S. V. Satyamurthy has resigned as Director of the Company vide his letter dated November 10, 2010 which has been accepted in the meeting of Board ....
Resignation of Director19 Nov · Management
Mr.S.V.Satyamurthy has resigned as Director of the Company vide his letter dated November 10, 2010 which has been accepted in the meeting of Board of Directors held on November 15, 2010.15 Nov · Results
2 Nov · Board meeting
To consider and take on record the Unaudited Financial Results and also Consolidated Financial Results of the Company for the quarter ended September 30, 2010.
Oct 2010
18 Oct · Updates
Company's factory at Ankleshwar has achieved record production for the month of September, 2010.18 Oct · Lyka Labs Ltd has informed BSE that the Company's factory at Ankleshwar has achieved record production for the month of September, 2010.
Record Production
Sep 2010
30 Sep · Business
Silver Patent Award30 Sep · Updates
Company has been conferred 'Silver Patent Award' by the Department of Pharmaceuticals, Ministry of Chemical & Fertilizers, Government of India and Pharmaceutical Export Promotion Council for the year 2009-10 in recognition of commendable contribution in Formulation Patents Category.
Aug 2010
19 Aug · Limited Review for the quarter ended Jun 30, 2010
14 Aug · Updates
A part of the Plant at Tarapur is undergoing upgradation from 1st August, 201014 Aug · Lyka Labs Ltd has informed BSE that a part of the Plant at Tarapur is undergoing upgradation from August 01, 2010.
Upgradation of Tarapur Manufacturing Plant12 Aug · Results
3 Aug · Board meeting
To consider and take on record the Un-audited Financial Results of the Company for the quarter ended June 30, 2010.
Jul 2010
Jun 2010
4 Jun · Lyka Labs Ltd has informed BSE that the Company has appointed Mr. Manish Jaywant as CFO w.e.f. June 01, 2010.
Appointment of CFO
May 2010
15 May · Results